Suchergebnisse - "Moermans, Catherine"

PubPharm (50)

11

Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis

enthalten in: Respiratory research | 2023

von Guiot, J. | Henket, M. | Remacle, C. | +9

12

Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis

enthalten in: Respiratory research | 2023

von Guiot, J. | Henket, M. | Remacle, C. | +9

13

A clustering analysis of eosinophilic asthmatics : Two clusters with sharp differences in atopic status and disease severity

enthalten in: Clinical & Experimental Allergy | 2023

von Zahraei, H. | Schleich, F. | Gerday, S. | +6

14

Severe Acute Respiratory Syndrome Coronavirus 2 detection in induced sputum of asthmatic patients using saliva sampling device

enthalten in: bioRxiv.org | 2022

von Moermans, C. | Gerday, S. | Bricmont, N. | +12

15

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD) : the bad phenotype ?

enthalten in: Respiratory research | 2022

von Guiot, J. | Henket, M. | Frix, A. | +9

16

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?

enthalten in: Respiratory research | 2022

von Guiot, J. | Henket, M. | Frix, A. | +9

17

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?

enthalten in: Respiratory research | 2022

von Guiot, J. | Henket, M. | Frix, A. | +9

18

Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction

enthalten in: Scientific reports | 2021

von Guiot, J. | Njock, M. | André, B. | +6

19

Serum IGFBP-2 in Systemic Sclerosis as a Protective Factor of Lung Dysfunction

enthalten in: ResearchSquare.com | 2021

von Guiot, J. | Njock, M. | André, B. | +6

20

Serum IGFBP-2 in Systemic Sclerosis as a Prognostic Factor of Lung Dysfunction

enthalten in: ResearchSquare.com | 2021

von Guiot, J. | Njock, M. | André, B. | +6